Cargando…

Immune cells as a potential therapeutic agent in the treatment of depression

INTRODUCTION: There are sufficient amount data on the immune cells and their biologically active products leading role in the pathogenesis of depression, which allows viewing modulated immune cells as model objects for developing new approaches to depression immunotherapy. OBJECTIVES: We first demon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markova, E., Knyazheva, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564873/ http://dx.doi.org/10.1192/j.eurpsy.2022.694

Ejemplares similares

Prospects for immunotherapy of depression based on cell technologies
por: Markova, E., et al.
Publicado: (2021)

Aggressive phenotype editing by modulated immune cells
por: Markova, E., et al.
Publicado: (2022)

Original compound with anticonvulsant activity in the treatment of alcoholism
por: Markova, E., et al.
Publicado: (2021)

Human type 2 macrophages biologically active soluble products in the editing of stress-induced depressive-like behavior
por: Markova, E., et al.
Publicado: (2021)

Efficiency of the original flavonoids composition based on Curcumin in chronic alcohol intoxication
por: Markova, E., et al.
Publicado: (2022)

The therapeutic potential of psilocybin in depression resistant to psychotropic drugs
por: Ramírez González, J., et al.
Publicado: (2023)

Cytokines status in multiple sclerosis patients with comorbid recurrent depressive disorder
por: Markova, E., et al.
Publicado: (2021)

Effect of original anticonvulsant ortho-fluoro-benzonal on immune cells functional properties at chronic ethanol intoxication
por: Markova, E., et al.
Publicado: (2022)

Proposal of a therapeutic algorithm for the psychopharmacological management of treatment-resistant depression
por: Sanz Giancola, A., et al.
Publicado: (2022)

Modulated in vitro lymphocytes in the treatment of alcoholism: Experimental study
por: Markova, E., et al.
Publicado: (2021)

Erythropoietin – a potential tool in the treatment of depressive disorders?
por: Simões, G., et al.
Publicado: (2022)

D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
por: MacKay, Mary-Anne B., et al.
Publicado: (2019)

Alcohol as a Therapeutic Agent
Publicado: (1913)

Therapeutic use of psychedelic drugs in depression disorders
por: Trigo, M.
Publicado: (2021)

Therapeutic education program in adults with unipolar depression
por: Halouani, N., et al.
Publicado: (2023)

Predicting Depression Severity from Spontaneous Speech as Prompted by a Virtual Agent
por: König, A., et al.
Publicado: (2023)

Climate as a Therapeutic Agent in Phthisis
por: Lindsay, James Alexander
Publicado: (1887)

Probiotics as a therapeutic strategy in Major Depressive Disorder
por: Vargas, L.
Publicado: (2022)

Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder
por: Rodrigues, J., et al.
Publicado: (2022)

The connection between diabetes and depression. Is coaching the best therapeutic path?
por: Farmakopoulou, I., et al.
Publicado: (2022)

Therapeutic management of major depression and psoriazis dual diagnosis
por: Vasiliu, O.
Publicado: (2021)

Is treatment resistant depression a different subtype of depression?
por: Fiorillo, A.
Publicado: (2021)

Gender Differences In The Therapeutic Evolution Of Major Depression during COVID-19 Pandemic
por: Navarro-Guzmán, C., et al.
Publicado: (2023)

Medication adherence in the treatment of depression
por: Pejuskovic, B., et al.
Publicado: (2023)

Suicidality in Treatment-Resistant Depression Patients
por: Lyubov, E. B., et al.
Publicado: (2023)

Model of therapeutic intervention in anorexia nervosa of adolescents with depressive behavioral disorders
por: Mykhailova, I., et al.
Publicado: (2021)

Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer
por: Lau, Tsz-Ying, et al.
Publicado: (2022)

Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19
por: Naik, Rajashri R., et al.
Publicado: (2022)

Prescribing exercise as a treatment for depression
por: Pereira, F., et al.
Publicado: (2021)

The efficacy psychobiotics for depression treatment
por: Denysov, Y., et al.
Publicado: (2023)

The use of light, temperature and pressure in the treatment of depression
por: Zalewski, D., et al.
Publicado: (2021)

PT598. Therapeutic potential of mesenchymal stem cells from different sources
por: Lee, Jeongmin, et al.
Publicado: (2016)

630. Identification of a Depressed Mucosal Immune Environment in HIV Infection
por: Sellers, Subhashini, et al.
Publicado: (2018)

γδ T cells as a potential therapeutic agent for glioblastoma
por: Kang, In, et al.
Publicado: (2023)

Therapeutic use of ayahuasca: a review of the evidence of its use in approaching depressive disorders
por: Simões, G., et al.
Publicado: (2022)

Clinical correlates of stress, immune and metabolic markers in major depression
por: Soria, V.
Publicado: (2023)

Circulating immune cell composition and activation status associate with brain white matter microstructure in bipolar depression
por: Benedetti, F.
Publicado: (2023)

The role of intranasal esketamine in treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

Therapeutic Potential of Natural Pharmacological Agents in the Treatment of Human Diseases
por: Ramana, Kota V., et al.
Publicado: (2014)

Stages of treatment of eating disorders in endogenous depressions
por: Barkhatova, A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gdgoshaon831f16j37vppdfltc